DR info

Clinical trials : 10 / Drugs : 7 - (DrugBank : 2) / Drug target genes : 2 - Drug target pathways : 2

Drugs and their primary sponsors and trial info

Curcumin
   Inoue Ken
      2018   -   JPRN-jRCTs031180348   Japan;
HuCNS-SC cells
   StemCells, Inc.
      2009   Phase 1   NCT01005004   United States;
HuCNS-SC transplant in the lead-in phase
   StemCells, Inc.
      2011   -   NCT01391637   United States;
Triac
   Erasmus Medical Center
      2014   Phase 2   NCT02060474   Netherlands;
   Rare Thyroid Therapeutics International AB
      2020   Phase 2   NCT02396459   Netherlands;
Téatrois (Tiratricol)
   Erasmus Medical Centre
      2016   Phase 2   EUCTR2014-000178-20-IT   Germany;Italy;
      2016   Phase 2   EUCTR2014-000178-20-FR   Australia;Belgium;Canada;Czech Republic;France;Germany;Italy;South Africa;
      2016   Phase 2   EUCTR2014-000178-20-CZ   Belgium;Czech Republic;Germany;Italy;
      2015   Phase 2   EUCTR2014-000178-20-BE   Australia;Belgium;Canada;Chile;Germany;Italy;South Africa;
      -   Phase 2   EUCTR2014-000178-20-DE   Australia;Belgium;Canada;Czech Republic;France;Germany;Israel;Italy;South Africa;